Healthcare (Substance Abuse)

S 921, titled "Tyler’s Law," requires the U.S. Department of Health and Human Services to study how often hospital emergency departments test for fentanyl during overdose cases, along with the costs, benefits, privacy impacts, and effects on patient-clinician relationships. The study must examine current testing frequency, associated costs, and how fentanyl testing might influence patient privacy and care. Within six months of completing the study, the Secretary must issue guidance on whether hospitals should routinely test for fentanyl, how to inform clinicians about testing protocols, and how such testing might affect future overdose risks and health outcomes. This bill directly affects hospitals with emergency departments and patients experiencing overdoses, but it does not mandate testing - it only mandates a study and subsequent guidance.

This bill creates a new grant program to help schools access naloxone for opioid overdose emergencies. It directly affects public and private elementary and secondary schools by requiring them to certify they have trained staff (like nurses or designated personnel), maintain accessible naloxone supplies, and have a plan for trained staff on-site during school hours. Schools must also confirm their state provides adequate legal protection for staff who administer naloxone. The grants, funded through the Public Health Service Act, support these requirements to enable immediate emergency treatment of opioid overdoses in school settings.

S 414, the ADS for Mental Health Services Act, requires major social media platforms and search engines (with over 100 million monthly users) to annually report to the Federal Trade Commission (FTC) on public service advertisements promoting mental, behavioral, or physical health resources. The reports must detail the number and value of such ads, including those highlighting free local services or addressing issues like suicide prevention, addiction, or social isolation. The FTC must then summarize this data for Congress annually, without altering existing privacy or data security laws. This bill directly affects large digital platforms by mandating transparency about health-focused public service advertising.

This document appears to be a comprehensive legislative bill, likely titled the "Pandemic and All-Hazards Preparedness and Response Act" or a similar public health bill. It contains numerous sections (numbered 201-625) with detailed provisions covering: 1. **Public Health Emergency Preparedness** - Sections 611-617 focus on strengthening state/local readiness, hospital preparedness, wastewater surveillance, and medical stockpiles. 2. **Opioid Crisis Response** - Sections 521-522, 531-539 address opioid prevention, treatment, recovery, and workforce development. 3. **Mental Health and Substance Use Disorder** - Sections 531-539 include grants for treatment, peer support, and workforce development. 4. **Suicide Prevention** - Section 518 focuses on protecting the National Suicide Prevention Lifeline from cybersecurity threats. 5. **Public Health Infrastructure** - Sections 621-625 cover medical countermeasures, antimicrobial resistance, and strategic stockpile management. 6. **Technical Corrections** - Sections 551-554 include technical amendments to controlled substances laws. The bill contains numerous funding authorizations (e.g., $735 million for Public Health Emergency Preparedness for fiscal years 2025-2026), reauthorizations of existing programs, and new initiatives aimed at strengthening the U.S. public health response system to both infectious disease threats and the opioid crisis. Without a specific question about this document, I've provided a general overview of its content and scope. If you have a specific question about any section or provision, please let me know.

This bill requires the Department of Veterans Affairs (VA) to commission an independent study comparing the quality of mental health and addiction therapy care provided by VA health care providers versus non-VA providers. The study must assess key factors like health outcome improvements, use of evidence-based practices, coordination between providers, veteran satisfaction, and care for veterans with co-occurring conditions. It will cover various treatment settings - including telehealth, inpatient, and outpatient care - and must be completed within 18 months, with results published publicly. The study directly affects veterans receiving mental health or addiction therapy services through VA or non-VA providers. The bill does not change benefits or funding but aims to gather data to inform future care decisions.

S 329, the Keeping Drugs Out of Schools Act of 2025, authorizes federal grants to fund partnerships between local anti-drug coalitions and schools to implement evidence-based drug prevention programs. It directly affects elementary, middle, and high schools in communities with existing Drug-Free Communities coalitions, providing up to $75,000 per school annually for these partnerships. The bill requires grantees to submit detailed implementation plans and use funds to supplement, not replace, existing prevention funding. It allocates $7 million yearly (2026-2031) for these programs, with no more than 8% of funds allowed for administrative costs.

The FOSTER Act (HR 6283) creates a new federal grant program to fund opioid abuse prevention and treatment services specifically for children and caregivers in kinship care settings. It directs states and local agencies to use these funds for workforce training, health care services, and recruiting foster/adoptive parents to support kinship caregivers - defined as relatives (by blood, marriage, or adoption) raising children when biological parents cannot. The bill authorizes $255 million annually from 2028 through 2033, with 1% of funds dedicated to these services. This policy directly affects state/local agencies and kinship caregivers across the U.S., focusing on improving support systems for children in these arrangements.

S 1656 establishes a compensation program for Vieques residents (in Puerto Rico) who developed specific illnesses - like cancer, diabetes, or heavy metal poisoning - due to 60+ years of U.S. military activity on the island. It awards $50,000 to $110,000 per qualifying illness based on the number of diseases, processed by a Special Master appointed by the Attorney General. The bill also mandates funding to build a new level-3 trauma medical facility with cancer and renal care, including interim services like air transport and telemedicine until the facility opens. All compensation and facility costs are capped at $1 billion, with claims needing to be filed within 15 years of the bill’s enactment.

Living Donor Protection Act of 2025 This bill prohibits life insurance, disability insurance, and long-term insurance carriers from denying or otherwise restricting coverage for living organ donors. Specifically, carriers may not deny, cancel, vary premiums, or otherwise impose conditions on policies based on an individual's status as a living organ donor. The bill also expressly specifies that recovery from organ-donation surgery constitutes a serious health condition that entitles eligible employees to job-protected medical leave. In addition, the Department of Health and Human Services must update educational materials on living organ donation to include information about the benefits and risks of living organ donation and the impact of donation on insurance access, particularly with respect to the bill's changes.

This bill updates federal grant programs to expand access to long-acting injectable medications, lab testing, and counseling for people with substance use disorders or serious mental illness. It requires grant recipients (state/local health agencies) to provide these specific services and train clinicians on medication use. The changes apply to new grants starting after the bill's enactment. Annual reports on program outcomes must also be submitted to Congress.